Boothbay Fund Management’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.13M | Hold |
693,693
| – | – | 0.06% | 286 |
|
|
2025
Q1 | $3.07M | Hold |
693,693
| – | – | 0.08% | 254 |
|
|
2024
Q4 | $5.43M | Buy |
693,693
+136,264
| +24% | +$1.07M | 0.13% | 182 |
|
|
2024
Q3 | $7.33M | Buy |
557,429
+188,069
| +51% | +$2.47M | 0.17% | 124 |
|
|
2024
Q2 | $4.46M | Buy |
369,360
+22,849
| +7% | +$276K | 0.11% | 219 |
|
|
2024
Q1 | $5.63M | Sell |
346,511
-347,583
| -50% | -$5.65M | 0.11% | 162 |
|
|
2023
Q4 | $4.73M | Buy |
694,094
+678,548
| +4,365% | +$4.63M | 0.12% | 174 |
|
|
2023
Q3 | $84.7K | Buy |
+15,546
| New | +$84.7K | ﹤0.01% | 1387 |
|
|
2021
Q4 | – | Sell |
-7,682
| Closed | -$219K | – | 2048 |
|
|
2021
Q3 | $219K | Sell |
7,682
-253
| -3% | -$7.21K | 0.01% | 1280 |
|
|
2021
Q2 | $268K | Buy |
+7,935
| New | +$268K | 0.01% | 1194 |
|